Literature DB >> 6131823

Nifedipine in the treatment of difficult hypertensives.

S Dean, M J Kendall.   

Abstract

Nifedipine has been assessed as a possible alternative to other third line drugs in the management of patients with difficult to control hypertension. A group of 20 patients whose blood pressure was unsatisfactory on a 3 drug regimen had their third drug stopped and after a 2 week period nifedipine was added to their beta-blocker plus diuretic therapy. Eleven became normotensive on 30 mg nifedipine daily and a further 6 on 60 mg daily; giving on overall success rate of 85%. This result was achieved with a reduction in side effects and an absence of any haemodynamic or metabolic complications.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131823     DOI: 10.1007/bf00613919

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography. Five commonly used beta blockers and hydralazine.

Authors:  D B Jack; S Dean; M J Kendall
Journal:  J Chromatogr       Date:  1980-01-04

2.  Detection of some antihypertensive drugs and their metabolites in urine by thin-layer chromatography: II. A further five beta blockers and dihydralazine.

Authors:  D B Jack; S Dean; M J Kendall; S Laugher
Journal:  J Chromatogr       Date:  1980-08-01

3.  HYDRALLAZINE.

Authors: 
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321

4.  Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.

Authors:  K Aoki; S Kondo; A Mochizuki; T Yoshida; S Kato; K Kato; K Takikawa
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

Review 5.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

6.  Evaluation of simple method to check compliance with antihypertensive drug therapy.

Authors:  D B Jack; S Dean; M J Kendall
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

7.  Haemodynamic effects of a calcium antagonistic agent (nifedipine) in hypertension: therapeutic implications.

Authors:  C Bartorelli; F Magrini; P Moruzzi; M T Olivari; A Polese; C Fiorentini; M Guazzi
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

8.  Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

9.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

10.  Nifedipine and propranolol: a beneficial drug interaction.

Authors:  H J Dargie; P G Lynch; D M Krikler; L Harris; S Krikler
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

View more
  9 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

3.  Disposition and hypoglycaemic action of glipizide in diabetic patients given a single dose of nifedipine.

Authors:  A A Connacher; A H el Debani; T E Isles; I H Stevenson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Drug treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 5.  Treatment of severe hypertension and hypertensive crises with nifedipine.

Authors:  M C Houston
Journal:  West J Med       Date:  1987-06

6.  Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.

Authors:  M J Kendall; D B Jack; S J Laugher; J Lobo; S Rolf Smith
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

7.  The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers.

Authors:  J Lobo; D B Jack; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Effects of BAY l 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: comparison with standard dose nifedipine.

Authors:  P Lejeune; W Gunselmann; L Hennies; K Hess; K Rittgerodt; K Winn; G Gfrerer; U Schreiber
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Role of nifedipine in treatment of hypertension.

Authors:  M B Murphy; A J Scriven; C T Dollery
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.